4//SEC Filing
Bhavnagri Veer 4
Accession 0001593968-22-001742
CIK 0001737287other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:29 PM ET
Size
5.1 KB
Accession
0001593968-22-001742
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Sale
Common Stock
2022-12-15$7.53/sh−5,602$42,186→ 583,677 total
Footnotes (2)
- [F1]1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001808980
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:29 PM ET
- Size
- 5.1 KB